Advisory Research’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,269
Closed -$492K 355
2022
Q4
$492K Buy
2,269
+472
+26% +$126K 0.05% 248
2022
Q3
$475K Buy
1,797
+157
+10% +$39.9K 0.05% 241
2022
Q2
$343K Sell
1,640
-1,082
-40% -$241K 0.03% 267
2022
Q1
$602K Sell
2,722
-53
-2% -$11.2K 0.05% 232
2021
Q4
$649K Buy
2,775
+868
+46% +$215K 0.05% 230
2021
Q3
$418K Sell
1,907
-408
-18% -$87.1K 0.03% 262
2021
Q2
$390K Buy
+2,315
New +$374K 0.03% 289
2018
Q4
Sell
-3,381
Closed -$337K 364
2018
Q3
$337K Buy
+3,381
New +$327K 0.01% 333
2018
Q1
Sell
-6,887
Closed -$881K 371
2017
Q4
$881K Sell
6,887
-14,455
-68% -$1.96M 0.01% 284
2017
Q3
$2.91M Buy
21,342
+2,539
+14% +$302K 0.05% 183
2017
Q2
$1.98M Sell
18,803
-13,085
-41% -$1.42M 0.03% 222
2017
Q1
$3.37M Buy
31,888
+3,760
+13% +$366K 0.05% 200
2016
Q4
$2.42M Buy
+28,128
New +$2.38M 0.04% 190

Other funds holding ALB

Advisory Research's ALB Position: Q1 2023 in Review

Advisory Research sold out of Albemarle (ALB) in Q1 2023, closing a stake of 2,269 shares — an estimated $492K sold.

Advisory Research first reported a position in ALB in Q4 2016 and held it in 13 quarters. The position peaked at $3.37M in Q1 2017. 1,024 funds tracked by Wall St. Rank hold ALB as of Q1 2023.

  • Advisory Research reported no remaining Albemarle position as of Q1 2023 after selling out during the quarter.
  • Advisory Research sold 2,269 Albemarle shares in Q1 2023, an estimated $492K.
  • Advisory Research first reported a position in Albemarle in Q4 2016 and held it in 13 quarters.
  • Advisory Research's Albemarle position peaked at $3.37M in Q1 2017.
  • 1,024 funds tracked by Wall St. Rank held Albemarle as of Q1 2023.

Based on Advisory Research's 13F filing for Q1 2023, filed 12 May 2023.